Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue European Journal of Medicinal Chemistry Année : 2016

Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives

Résumé

Following our research for new melatonergic ligands, herein we report the design, synthesis and biological evaluation of new series of naphthofuranic derivatives as MT1 and MT2 ligands. Binding affinity results of the prepared compounds revealed good binding affinities at both melatonin receptor subtypes. Particularly, compound 6a behaved as an MT1 partial agonist and MT2 full agonist and exhibited an excellent binding affinity at MT2 (Ki = 0.09 nM). In addition, lateral chain displacement from position 1 to 2 of the furan core had no effect on the binding affinity at both MT1 and MT2, while elongation of this side chain, led to decreased melatonergic binding affinities.
Fichier principal
Vignette du fichier
EJMC_2016, 109, 360-70..pdf (328.42 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-02060776 , version 1 (08-03-2019)

Identifiants

Citer

Elodie Landagaray, Mohamed Ettaoussi, Romain Duroux, J.A. Boutin, Daniel-Henri Caignard, et al.. Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives. European Journal of Medicinal Chemistry, 2016, 109, pp.360-370. ⟨10.1016/j.ejmech.2015.12.047⟩. ⟨hal-02060776⟩

Collections

INSERM UNIV-LILLE
23 Consultations
108 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More